Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost
Name:
37397380.pdf
Size:
4.954Mb
Format:
PDF
Description:
Identified with Open Access button
Authors
Shortall, JaneVasquez Osorio, Elina
Green, Adèle C
McWilliam, Alan
Elumalai, Thriaviyam
Reeves, Kimberley
Johnson-Hart, Corinne
Beasley, William J
Hoskin, Peter J
Choudhury, Ananya
van Herk, Marcel
Affiliation
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, ManchesterIssue Date
2023
Metadata
Show full item recordCitation
Shortall J, Vasquez Osorio E, Green A, McWilliam A, Elumalai T, Reeves K, et al. Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost. Frontiers in oncology. 2023;13:1200676. PubMed PMID: 37397380. Pubmed Central PMCID: PMC10311256. Epub 2023/07/03. eng.Journal
Frontiers in OncologyDOI
10.3389/fonc.2023.1200676PubMed ID
37397380Additional Links
https://dx.doi.org/10.3389/fonc.2023.1200676Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.3389/fonc.2023.1200676
Scopus Count
Collections
Related articles
- Outcomes of Asian patients with localized prostate cancer treated with combined intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy: A single institution experience.
- Authors: Ng IWS, Tey JCS, Soon YY, Tseng MSF, Chen D, Lim KHC
- Issue date: 2018 Oct
- Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.
- Authors: Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M 3rd, Phillips T
- Issue date: 2000 Mar 1
- A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients.
- Authors: Joseph N, Taylor C, O'Hara C, Choudhury A, Elliott T, Logue J, Wylie J
- Issue date: 2016 Nov
- Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
- Authors: Dutta SW, Bauer-Nilsen K, Sanders JC, Trifiletti DM, Libby B, Lash DH, Lain M, Christodoulou D, Hodge C, Showalter TN
- Issue date: 2018 May-Jun
- Four-year outcomes of hypofractionated high-dose-rate prostate brachytherapy and external beam radiotherapy.
- Authors: Chen WC, Tokita KM, Ravera J, Fu P, Jiang Y, Kaminsky DA, Ponsky L, Ellis RJ
- Issue date: 2013 Sep-Oct